Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Teratoid Tumor, Atypical 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Gliosarcoma 1Glioblastoma 1Choroid Plexus Neoplasms 1Brain Stem Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 6Cyclophosphamide 4antineoplaston AS 2-1 3antineoplaston A10 3Radiotherapy 3Filgrastim 3sargramostim 2aldesleukin 2Vincristine 2Thalidomide 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Irinotecan 2Donepezil 2Cisplatin 2Carmustine 2Bevacizumab 2veliparib 1trametinib 1temsirolimus 1surufatinib 1spartalizumab 1sonidegib 1ribociclib 1reolysin 1plerixafor 1ganitumab 1fosbretabulin 1entinostat 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors, Primitive × azurin (50-77) × Clear all
NCT01975116 2017-08-07

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
18 enrolled
CNSSarcoma

Teratoid Tumor, Atypical, Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡